BARTON NAKDIMEN: Open Payments
NPI 1245304625 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,599 in 133 payments from 15 companies in 2025. Trend: 2023 $2,609 · 2024 $3,264 · 2025 $2,599
Food & beverage: $2,599
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $880 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $367 |
| Janssen Biotech, Inc. | 18 | $294 |
| Aimmune Therapeutics, Inc. | 11 | $278 |
| Madrigal Pharmaceuticals | 9 | $228 |
| PFIZER INC. | 6 | $154 |
| Gilead Sciences, Inc. | 5 | $112 |
| Novo Nordisk Inc | 2 | $55 |
| Phathom Pharmaceuticals, Inc. | 5 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
Products named: RINVOQ, XIFAXAN, TREMFYA, SKYRIZI, ZENPEP, REZDIFFRA, XELJANZ, Linzess.
Industry payments across TN — which companies pay providers there.
